The Relationship Between Inhibitors of Eukaryotic and Prokaryotic Serine Proteases

Author(s): Monika I. Konaklieva, Balbina J. Plotkin.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 4 , Issue 7 , 2004

Become EABM
Become Reviewer


The ability to inhibit serine proteases is a major focus in the pharmaceutical industry. Serine proteases of medical importance range in phylogenetic diversity from the metallo-proteases, which play a role in pulmonary hypertension, and destruction of the lung parenchyma in emphysema, to those proteases (betalactamases), which play a role in the resistance of bacteria to beta-lactam antibiotics. In both the mammalian and microbial systems, the development of serine protease inhibitors has been a focal strategy spurring investigations in the area of serine protease dependent prodrugs that incorporate a bactericidal moiety as well as other classes of metalloprotease inhibitors.

Keywords: serine proteases, lactamases, human leukocyte elastase, serine protease inhibitors

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2004
Page: [721 - 739]
Pages: 19
DOI: 10.2174/1389557043403611
Price: $65

Article Metrics

PDF: 5